The standard of care for patients with unprotected left main coronary artery (ULMCA) disease is coronary artery bypass grafting (CABG) based largely on older, outdated data which demonstrate improved survival as compared with medical therapy and poor outcomes with balloon angioplasty.(1-3) But, given the data which demonstrate that ULMCA percutaneous coronary intervention (PCI) with drug-eluting stents (DES) is safe and effective, the 2009 American College of Cardiology (ACC)/American Heart Association (AHA) focused guidelines for PCI state that ULMCA stenting may be considered in patients with anatomic conditions that are associated with a low risk of procedural complications and clinical conditions that predict an increased risk of adverse surgical outcomes.(4) read more

The rest is here:
Unprotected Left Main Coronary Artery PCI in Acute Myocardial Infarction

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

ABSTRACT: Objective. To examine the 1-year safety and clinical outcomes associated with the post-marketing early unselected use of sirolimus-eluting stents (SES) in the United States

See the original post here:
Outcomes of Unselected Recipients of Sirolimus-Eluting Stents: The Cypher® Stent U.S. Post-Marketing Surveillance Registry

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.